Envoy Medical holds special stockholder meeting
COCH•Envoy Medical shareholders approved authorization for one or more reverse stock splits of Class A Common Stock at ratios from 1-for-5 to 1-for-25. The board may implement them through December 31, 2026; shareholders also approved an adjournment proposal, which was not used.
1. Shareholders approve authorization
At a special meeting on October 12, 2026, Envoy Medical shareholders approved authorization for one or more reverse stock splits of Class A Common Stock at ratios from 1-for-5 to 1-for-25. Implementation is at the board’s discretion, with authority to execute the splits through December 31, 2026.
2. Adjournment proposal approved
Shareholders also approved a proposal allowing the meeting to be adjourned to gather necessary votes or ensure a quorum. That authority was not used.
